525 related articles for article (PubMed ID: 19250546)
21. Large-scale analysis of
Croes L; Beyens M; Fransen E; Ibrahim J; Vanden Berghe W; Suls A; Peeters M; Pauwels P; Van Camp G; Op de Beeck K
Clin Epigenetics; 2018; 10():51. PubMed ID: 29682089
[TBL] [Abstract][Full Text] [Related]
22. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
23. Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis.
Marzese DM; Scolyer RA; Huynh JL; Huang SK; Hirose H; Chong KK; Kiyohara E; Wang J; Kawas NP; Donovan NC; Hata K; Wilmott JS; Murali R; Buckland ME; Shivalingam B; Thompson JF; Morton DL; Kelly DF; Hoon DS
Hum Mol Genet; 2014 Jan; 23(1):226-38. PubMed ID: 24014427
[TBL] [Abstract][Full Text] [Related]
24. [Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].
Zhang N; Sun ZZ; Li F; Cao YW; Zhao CX; Liang WH; Sun HP; Li HA; Fu XG
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):324-9. PubMed ID: 21756827
[TBL] [Abstract][Full Text] [Related]
25. Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis.
Faryna M; Konermann C; Aulmann S; Bermejo JL; Brugger M; Diederichs S; Rom J; Weichenhan D; Claus R; Rehli M; Schirmacher P; Sinn HP; Plass C; Gerhauser C
FASEB J; 2012 Dec; 26(12):4937-50. PubMed ID: 22930747
[TBL] [Abstract][Full Text] [Related]
26. DNA methylation of GHSR, GNG4, HOXD9 and SALL3 is a common epigenetic alteration in thymic carcinoma.
Kishibuchi R; Kondo K; Soejima S; Tsuboi M; Kajiura K; Kawakami Y; Kawakita N; Sawada T; Toba H; Yoshida M; Takizawa H; Tangoku A
Int J Oncol; 2020 Jan; 56(1):315-326. PubMed ID: 31746370
[TBL] [Abstract][Full Text] [Related]
27. Methylation profiling of ductal carcinoma in situ and its relationship to histopathological features.
Pang JM; Deb S; Takano EA; Byrne DJ; Jene N; Boulghourjian A; Holliday A; Millar E; Lee CS; O'Toole SA; Dobrovic A; Fox SB
Breast Cancer Res; 2014 Oct; 16(5):423. PubMed ID: 25331261
[TBL] [Abstract][Full Text] [Related]
28. Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer.
Muggerud AA; Rønneberg JA; Wärnberg F; Botling J; Busato F; Jovanovic J; Solvang H; Bukholm I; Børresen-Dale AL; Kristensen VN; Sørlie T; Tost J
Breast Cancer Res; 2010; 12(1):R3. PubMed ID: 20056007
[TBL] [Abstract][Full Text] [Related]
29. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters.
Shen L; Kondo Y; Guo Y; Zhang J; Zhang L; Ahmed S; Shu J; Chen X; Waterland RA; Issa JP
PLoS Genet; 2007 Oct; 3(10):2023-36. PubMed ID: 17967063
[TBL] [Abstract][Full Text] [Related]
31. A multifactorial signature of DNA sequence and polycomb binding predicts aberrant CpG island methylation.
McCabe MT; Lee EK; Vertino PM
Cancer Res; 2009 Jan; 69(1):282-91. PubMed ID: 19118013
[TBL] [Abstract][Full Text] [Related]
32. CpG island methylator phenotype of multigene in serum of sporadic breast carcinoma.
Jing F; Yuping W; Yong C; Jie L; Jun L; Xuanbing T; Lihua H
Tumour Biol; 2010 Aug; 31(4):321-31. PubMed ID: 20490964
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
[TBL] [Abstract][Full Text] [Related]
34. Frequent methylation of the KLOTHO gene and overexpression of the FGFR4 receptor in invasive ductal carcinoma of the breast.
Dallol A; Buhmeida A; Merdad A; Al-Maghrabi J; Gari MA; Abu-Elmagd MM; Elaimi A; Assidi M; Chaudhary AG; Abuzenadah AM; Nedjadi T; Ermiah E; Alkhayyat SS; Al-Qahtani MH
Tumour Biol; 2015 Dec; 36(12):9677-83. PubMed ID: 26152288
[TBL] [Abstract][Full Text] [Related]
35. Differential methylation hybridization profiling identifies involvement of STAT1-mediated pathways in breast cancer.
Kim JH; Kang HS; Kim TW; Kim SJ
Int J Oncol; 2011 Oct; 39(4):955-63. PubMed ID: 21674123
[TBL] [Abstract][Full Text] [Related]
36. HOXD13 methylation status is a prognostic indicator in breast cancer.
Zhong Z; Shan M; Wang J; Liu T; Xia B; Niu M; Ren Y; Pang D
Int J Clin Exp Pathol; 2015; 8(9):10716-24. PubMed ID: 26617782
[TBL] [Abstract][Full Text] [Related]
37. DNA methylation index and methylation profile of invasive ductal breast tumors.
Marzese DM; Hoon DS; Chong KK; Gago FE; Orozco JI; Tello OM; Vargas-Roig LM; Roqué M
J Mol Diagn; 2012 Nov; 14(6):613-22. PubMed ID: 22925694
[TBL] [Abstract][Full Text] [Related]
38. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
39. Intratumor heterogeneity index of breast carcinomas based on DNA methylation profiles.
Campoy EM; Branham MT; Mayorga LS; Roqué M
BMC Cancer; 2019 Apr; 19(1):328. PubMed ID: 30953488
[TBL] [Abstract][Full Text] [Related]
40. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]